Edwards Lifesciences Corporation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
Edwards Lifesciences Corporation (EW) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $0 for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-27.
Discontinued › Notes
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2018-04-27
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2017-12-31 was $59.70M.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2017-09-30 was $0.00.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2017-06-30 was $0.00.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2017 was $222.60M.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2015 was $30.30M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-04-27 | $59.70M derived: sum of 2 quarters · filed 2018-04-27 | $59.70M derived: sum of 3 quarters · filed 2018-04-27 | $59.70M derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-12-31 | $59.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $59.70M derived: sum of 2 quarters · filed 2018-02-16 | $59.70M derived: sum of 3 quarters · filed 2018-02-16 | $222.60M 10-K · filed 2018-02-16 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $0.00 derived: sum of 2 quarters · filed 2017-10-27 | $162.90M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $162.90M 10-Q · filed 2017-07-28 | ||
| 2017-03-31 | $162.90M 10-Q · filed 2017-04-28 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-02-17 | |||
| 2015-12-31 | $30.30M 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |